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Abstract
Maternal prenatal anxiety is an important risk factor for altered child neurodevelopment but
there is uncertainty concerning the biological mechanisms involved and sources of individ-
ual differences in children’s responses. We sought to determine the role of functional
genetic variation in COMT, which encodes catechol-O-methyltransferase, in the association
between maternal prenatal anxiety and child symptoms of ADHD and working memory. We
used the prospectively-designed ALSPAC cohort (n = 6,969) for our primary data analyses
followed by replication analyses in the PREDO cohort (n = 425). Maternal prenatal anxiety
was based on self-report measures; child symptoms of ADHD were collected from 4–15
years of age; working memory was assessed from in-person testing at age 8 years; and
genetic variation in COMT at rs4680 was determined in both mothers and children. The
association between maternal prenatal anxiety and child attention/hyperactivity symptoms
and working memory was moderated by the child’s rs4680 genotype, with stronger effects
obtained for the val/val (G:G) genotype relative to val/met (A:G) (all p<0.01) and met/met
(A:A) groups (all p<0.05). Similar findings were observed in the PREDO cohort where
maternal prenatal anxiety interacted with child rs4680 to predict symptoms of ADHD at 3.5
years of age. The findings, from two cohorts, show a robust gene-environment interaction,
which may contribute to inter-individual differences in the effects of maternal prenatal anxi-
ety on developmental outcomes from childhood to mid-adolescence.
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Introduction
There is now a sizable evidence base from research groups in several countries linking psycho-
logical distress in pregnancy with altered neurodevelopment—cognitive and intellectual abili-
ties, executive functions, language, and brain imaging—in the children, adolescents and young
adults [1–10]. These findings provide leads in identifying mechanisms of brain development,
highlight the significance of prenatal exposures for child neurodevelopment, and expand the
public health implications of maternal prenatal distress for the mother and child. The current
study extends this research by investigating sources of individual differences in the link
between prenatal maternal anxiety and child neurodevelopment.
Genetic variation is a likely source of differences in response to prenatal maternal mood; a
focus on COMT is particularly relevant for research on neurodevelopment. A functional single
nucleotide polymorphism (SNP) within COMT (val158met; rs4680) results in a valine to
methionine mutation and is strongly related to COMT enzyme activity. Compared with the
val allele, the met allele is associated with significantly lower enzymatic activity. This is of par-
ticular importance in brain regions such as the prefrontal cortex in which COMT is one of the
principal regulators of extracellular dopamine levels, resulting in higher levels of dopamine
and lower dopamine turnover in met homozygotes (A:A genotype) compared with carriers of
the val/val (G:G genotype)[11]. Numerous studies report that individuals with one or two cop-
ies of the val allele exhibit poorer performance on neurodevelopmental assessments in adults
[12] and children [13] and exhibit greater vulnerability for psychiatric disorder associated with
deficits in neurodevelopment [14]. Furthermore, Knickmeyer and colleagues reported reduced
volume in the temporal cortex associated with the val/val homozygote in their study of new-
borns [15].
Relevant to the current study is evidence that the well-documented association between
prenatal maternal anxiety or stress and child outcome cited above may be moderated by the
child’s COMT genotype [16]. A report from Singapore on 146 neonates indicated that the asso-
ciation between prenatal maternal anxiety and neonatal cortical morphometry was moderated
by genetic variation in COMT [16], with increased thickness of the ventrolateral prefrontal cor-
tex observed in neonates with the val allele. This finding is notable in suggesting that COMT
may be involved in early brain development and, therefore, relevant for studies of prenatal
anxiety. The finding is also notable for extending the focus in prenatal maternal anxiety and
stress research beyond glucocorticoids to also include dopamine-mediated mechanisms. On
the other hand, it is not yet clear if COMT moderation of prenatal maternal anxiety represents
a robust effect, on other child outcomes. A report of 546 children using a measure of maternal
perceived stress at one-day postpartum suggested that child rs4680 may moderate prenatal
exposure [17], with poorer outcomes on a composite measure of total behavioral and emo-
tional problems observed in met/met homozygotes. Given the potential significance of these
findings for identifying alternative biological mechanisms, replication is warranted and exten-
sion is needed to other measures of neurodevelopment and to assessments beyond infancy.
In the current study we describe the effects of maternal prenatal anxiety on two key markers
of neurodevelopment in the child: a) working memory as assessed from in-person standard-
ized testing and b) attention problems from measures at 4 and 15 years of age. We examine
child rs4680 as a main effect and moderator of the prenatal anxiety exposure. The longitudinal
assessment of symptoms of inattention and hyperactivity from preschool through mid-adoles-
cence available in the current study with the ALSPAC cohort, provided a rare opportunity to
examine genetic moderation of the prenatal prediction across a period of dramatic change in
neurodevelopment. Based on our previous research [4, 18] and the limited research cited
above, we hypothesized that variation at rs4680 would moderate the association between
Prenatal anxiety, COMT and child outcome
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maternal prenatal anxiety and ADHD-related child outcomes. We test this hypothesis in a
large prospective longitudinal cohort and a smaller independent replication sample. We also
apply stringent controls for type 1 errors associated with gene-environment analyses [19].
Materials and methods
Primary study sample
Data for this study are part of the Avon Longitudinal Study of Parents and Children
(ALSPAC), an ongoing population-based study designed to investigate the effects of a wide
range of influences on the health and development of children [20]; details available at http://
www.bris.ac.uk/alspac. The study cohort consisted of 14,541 pregnancies and 13,971 children
who were still alive at 12 months of age. The current analyses focus on mothers and their child
(n = 6,969; see inclusion criteria below) who provided biological samples for genetic analyses,
questionnaire data on their child’s emotional and behavioral development at 4 years of age
and a subset of these who returned at age 8 and 15 years for an in-person assessment in the
research clinic. Written informed consent was obtained from parents, while children provided
assent after receiving a full explanation of the study; ethical approval for all measures was
obtained from the ALSPAC Ethics and Law Committee and from Local Research Ethics
Committees.
Measures
Maternal anxiety and depressive symptoms in pregnancy and the postnatal period.
Maternal prenatal anxiety was based on the anxiety subscale of the Crown-Crisp experiential
index (CCEI) and the Spielberger Trait Anxiety Inventory (STAI), both well-validated self-rat-
ing questionnaires with good disriminant validity and internal consistency for the CCEI
(Cronbach’s α = 0.74; [21, 22]) and STAI (Cronbach’s α 0.86; [23]). Data were collected at
18 and 32 weeks gestation and at 8 weeks and 33 months postpartum (CCEI), and at 97
months postpartum (STAI). In our analyses we include a measure of maternal anxiety at 8
weeks postnatal (to account for particular effects in the immediate postnatal period), at 33
months (the point closest in time to the first assessment of child symptoms of ADHD) or at 97
months (the point closest in time to the assessment of adolescent symptoms); see data analysis
section. Although our primary interest is in prediction from prenatal anxiety based on previ-
ous literature (e.g., [16]), we also consider maternal depressive symptoms based on maternal
self-reports on the Edinburgh postnatal depression scale (EPDS), a ten item questionnaire
shown to be valid both in and outside of the postnatal period [24, 25]. We include depression
in analyses to examine the specificity of the interaction effect between maternal prenatal mood
disturbance and child genotype on child health outcomes given that maternal depression, anx-
iety and stress may have differential effects on child outcomes [26].
Paternal symptoms of anxiety and depression were assessed using the CCEI and EPDS at
one time point during pregnancy (18 weeks gestational age) and from 8 weeks to 33 months
postpartum. We incorporate measures of paternal mood to examine the specificity of the inter-
action between measures of parental mood in the prenatal period and child COMT genotype.
If the effects of maternal prenatal mood on child outcome are moderated by child COMT
genotype, and these effects are specific to events occuring in utero, then we would expect a
stronger prediction from maternal rather than paternal prenatal anxiety.
Child attention problems. Child ADHD symptoms at age 4 years based on maternal
report were assessed using the Strengths and Difficulties questionnaire (SDQ), a widely used
and well-validated assessment of child emotional and behavioral problems [27]. When the
children were approximately 15 years of age, mothers provided information on child ADHD
Prenatal anxiety, COMT and child outcome
PLOS ONE | https://doi.org/10.1371/journal.pone.0177506 June 14, 2017 3 / 16
symptoms using the Development and Well-Being Assessment (DAWBA), a structured inter-
view with considerable evidence for its clinical validity and reliability [28]. The DAWBA data
are presented in probability bands that assess the likely prevalence of ADHD in one of six
bands, e.g., Band 1 (<0.1%) =<0.1% of children in this band have the disorder in question,
Band 2 (~0.5%) = ~0.5% of children in this band have the disorder in question, through to
Band 6 (>70%) in which>70% of children in this band are likely to have the disorder in ques-
tion [29].
General cognitive ability and working memory. Child backward digit span task [30]
from the the Weschler Intelligence Scale for Children (WISC-III) [31] was assessed as part of
an in-person standardized assessment of cognitive ability at 8 years of age. We focus our analy-
ses on the backward digit span as a measure of working memory linked to central executive
function (see [32, 33]). We also include in our analyses forward digit span and overall IQ.
COMT rs4680 genotype. Genotyping methods used within ALSPAC have been described
previously [34] and COMT genetic methods have been previously reported [35]. DNA was
obtained from whole blood samples. COMT rs4680 was determined using a 50-nuclease fluo-
rescence assay; primer/probe combinations were designed using Primer Express software (2.0)
and allele discrimination performed using the Taqman 7900 PCR system (ABI, Foster City,
Calif.). Allelic frequencies are provided in Table 1. Paired maternal rs4680 data were available
on a subsample of this cohort (n = 4,590: AA n = 1214, AG n = 2296, GG n = 1080).
Our focus is on COMT (rs4680) because it has a clear link with neurodevelopment and has
been investigated in prior work on genetic moderation, but we also include, for exploratory
purposes, analyses of BDNF (rs11030121 and rs7124442), which we have previously shown to
moderate maternal prenatal anxiety in predicting child emotional problems [36].
Obstetric and psychosocial covariates. Several possible covariates indexing socio-eco-
nomic, demographic, and psychosocial risk were considered. Maternal education (highest edu-
cational achievement within the UK educational system according to 4 categories ranging
from Certificate of Secondary Education/vocational training to university degree or higher
degree) and household crowding (a 4-point scale created by dividing the number of people in
the household by the number of rooms: 0–0.50, 0.50–0.75, 0.75–1.00 and> 1.00) at time of
pregnancy were used as measures of maternal socioeconomic status. Data on prenatal risk fac-
tors such as maternal age, smoking and alcohol/substance abuse were collected during preg-
nancy. Birthweight and gestational age were recorded from medical notes. We did not exclude
any participants based on birthweight or preterm birth however both obstetric outcomes were
included as covariates in all analyses. At 24 months mothers completed a series of questions
related to the frequency of positive (e.g., playing, cuddling, eating with, or praising child) and
negative (e.g., slapping and shouting) parenting behaviors, which were summed to calculate a
parenting score ranging from 18 (low) to 40 (high) [37]. The ALSPAC study website contains
details of all the data that is available through a fully searchable data dictionary (http://www.
bris.ac.uk/alspac/researchers/data-access/data-dictionary).
Data analysis
After presenting descriptive data, we report bivariate associations between COMT rs4680 and
prenatal risk and child outcomes. Analyses testing our primary hypothesis focus on the prena-
tal assessment of maternal anxiety at 32 weeks; maternal postnatal anxiety at 8 weeks and 33 or
97 months are included as controls in order to examine if there is a particular effect of mater-
nal anxiety in pregnancy using linear regression models. For analyses of child working mem-
ory at age 8 years, we include total IQ as a control for general cognitive ability. All regression
analyses account for obstetric, demographic, psychosocial covariates. We report unadjusted
Prenatal anxiety, COMT and child outcome
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p-values and p-values corrected for multiple testing (x3 tests) based on the number of main
study outcomes (see S1 File). After reporting the main analyses for maternal prenatal anxiety
at 32 weeks gestation, we report supplementary analyses to examine if our predicitve models
are robust to a series of confounds associated with gene-environment analyses. We tested if
our results were robust to potential heteroskedacity using a seriers of robust joint tests imple-
mented in PLINK [19]. Likewise, we implemented the approach of Keller [38] to eliminate
covariate × environment or covariate × gene interactions as potential confounds in our analyt-
ical models. We then carry out a series of analyses to examine the specificity of the interaction
between maternal mood and child genotype to predict child outcome. We test if 1) there are
prenatal developmental timing effects (using the prenatal maternal anxiety assessment at 18
weeks gestation); 2) if the genetic moderation is specific to in utero exposure (by including
Table 1. Maternal mood, child and adolescent outcomes across rs4680 genotypes.
COMT rs4680
Maternal mood AA (Met/Met) GA(Val/Met) GG (Val/Val)
Mean (SD) Mean (SD) Mean (SD)
Prenatal anxiety (32 wks) 4.88 (3.48) 4.90 (3.52) 4.93 (3.45)
n 1888 3426 1655
Postnatal anxiety (8 wks) 3.29 (3.31) 3.29 (3.17) 3.29 (3.22)
n 1832 3348 1598
Postnatal depression (8 wks) 5.79 (4.66) 5.86 (4.61) 5.88 (4.65)
n 1858 3378 1619
Maternal anxiety (33 mths) 4.55 (3.46) 4.56 (3.52) 4.58 (3.45)
n 1636 2984 1422
Maternal depression (33 mths) 6.12 (4.94) 6.00 (4.97) 6.12 (4.85)
n 1640 2984 1420
Maternal anxiety (8 yrs) 39.37 (9.18) 39.19 (9.05) 38.92 (8.76)
n 1297 2399 1134
Child outcomes
ADHD symptoms (SDQ) (4 yrs) 3.96 (2.33) 3.88 (2.32) 3.97 (2.32)
n 1583 2909 1415
Total IQ (WISC) (8 yrs) 105.87 (16.18)* 104.77 (16.21) 104.26 (15.88)
n 1341 2491 1193
Forwards digit span (8 yrs) 5.30 (1.08) 5.28 (1.07) 5.27 (1.12)
Backward digit span (8 yrs) 3.55 (0.81) 3.52 (0.84) 3.54 (0.85)
DAWBA Bands (15 yrs)
%per group with likely ADHD
AA (Met/Met) n = GA(Val/Met) n = GG (Val/Val) n =
<0.1% 672 1187 572
~0.5% 133 253 109
~3% 50 101 64
~15% 24 56 33
~50% 4 7 3
>70% 1 7 3
Table presents descriptive statistics for measures of maternal mood, child and adolescent outcomes.
Between-group differences were tested using one-way ANOVA and X2 tests where appropriate. Percent
Likelihood of ADHD per group at 15 years is based on the Development and Well-Being Assessment.
SDQ = Strengths and Difficulties Questionnaire. WISC = Wechsler Intelligence Scale for Children.
*One-way ANOVA F(2, 5022) = 3.44, p = 0.03 Fischer’s least significant difference AA vs AG p = 0.04, AA vs
GG p = 0.01. wks = weeks, mths = months, yrs = years.
https://doi.org/10.1371/journal.pone.0177506.t001
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moderation analyses of postnatal maternal anxiety and prenatal paternal anxiety); 3) if the pre-
natal anxiety effects are particular to anxiety or extend to maternal depression and if modera-
tion effects are specific to genetic variation in COMT or extend to genetic variation in BDNF.
For the latter analysis we focus on two SNPs in BDNF (rs11030121 and rs7124442) shown to
moderate the effects of maternal prenatal anxiety on child internalizing symptoms.
Consistent with general practice, we did not include a missing data strategy where genetic
data were not available; consequently, our sample size varies as a function of genetic data avail-
ability. The ALSPAC cohort is largely composed of Caucasian (>90%) participants. Given the
small number of non-Caucasian participants, and potential influence of ethnicity on genotype
frequencies, we focused our genetic analyses exclusively on Caucasians.
Replication analyses
Sample. The PREDO cohort includes 4777 women recruited to the study between 2005
and 2009 at their first antenatal visits [39]. The final replication sample was comprised 425
mothers and their children with data available on maternal prenatal mood, child rs4680 geno-
type and symptoms of ADHD. The mothers participating in our study did not differ from
other PREDO cohort mothers in their anxiety symptoms at any assessment point during preg-
nancy (all p-values.13) and the participating children did not differ from other PREDO chil-
dren in their rs4680 genotype or ADHD symptoms (all p-values.10). The PREDO study
protocol was approved by ethical committees of the Helsinki and Uusimaa Hospital District.
Measures. Maternal mood: Maternal anxiety symptoms were assessed with Beck Anxiety
Inventory (BAI) at 32 weeks of gestation, 2 weeks postpartum, and 1.9–6.1 years after preg-
nancy. The BAI has excellent psychometric properties and good internal consistency (cron-
bach’s α = 0.92) [40].
COMT rs4680 genotype: Child genotyping was performed with Illumina Human Omni
Express Exome 1.2. array. Rs4680 was directly genotyped and showed a call rate of 1.0, no devi-
ation from Hardy-Weinberg equilibrium (p = .85), and minor allele frequency of 0.47 (G:G
n = 92, G:A n = 214, A:A n = 119).
Child ADHD symptoms: Child ADHD symptoms over the past month were evaluated
using the Conners’ 10-item scale [41]. Conners’ ADHD scale scores were square-root trans-
formed to attain normality.
Results
Table 1 provides descriptive data for measures of maternal mood and child neurodevelopmen-
tal outcomes according to child COMT (rs4680) genotypes. Attrition analyses indicated signifi-
cant group differences in sociodemographic factors between participants providing data on
maternal prenatal anxiety and child rs4680 and the remainder of the ALSPAC cohort. Partici-
pants included in our analysis were born to women who were older (t = -16.495, p<0.001),
more educated (Χ2 = 195.529, p< .001) and who reported less household crowding (Χ2 =
267.216, p < .001) than the remainder of the ALSPAC cohort. Although significant (due to the
large sample size), these group differences represented small effects (all Cohen’s d<0.29);
these covariates were included in all analytical models described below to account for potential
bias.
Child total IQ was associated with rs4680 in a univariate analysis (F(2, 5022) = 3.44, p = 0.03).
Post-hoc analyses indicated that children homozygous for the met allele showed higher total
IQ compared to both other groups (Fischer’s least significant difference met/met vs val/met
p = 0.04, met/met vs val/val p = 0.01, respectively); effect sizes can be estimated from results in
Table 1. However, rs4680 was not significantly associated with child (r = 0.002, p = 0.881) or
Prenatal anxiety, COMT and child outcome
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adolescent ADHD symptoms (r = 0.031, p = 0.074), or backward digit span test at age 8 years
(r = -0.006, p = 0.690).
Child rs4680 genotype was not significantly associated with measures of pre- or postnatal
maternal mood (r = -0.014–0.009, all p0.295) implying no confound of gene-environment
correlation; neither was maternal prenatal anxiety or depression (at 18 or 32 weeks gestation)
significantly associated with maternal rs4680 genotype (all p>0.222). Furthermore, for each
child outcome there was no significant two-way interaction between child gender and mater-
nal prenatal anxiety (all p 0.244) or between child gender and child rs4680 genotype (all
p 0.441). Likewise we did not observe a significant three-way interaction (maternal prenatal
anxiety x child gender x child rs4680) in the prediction of the main study outcomes (all
p 0.097); therefore, males and females were combined and child gender was included as a
covariate in all analyses.
Child rs4680, maternal prenatal anxiety and working memory at age 8
years
A regression model which examined the main effects of our genetic and environmental predic-
tors accounted for a significant proportion of the variance in child backwards digit span
(R2 = 0.030, p<0.001). We also observed a significant interaction between maternal prenatal
anxiety at 32 weeks and child rs4680 in predicting backward digit span at age 8 years: children
with the val/val alleles exhibited a significantly shorter backward digit span with increasing
prenatal maternal anxiety, after covarying a range of psychosocial and obstetric measures (Fig
1). The addition of the interaction term (maternal prenatal anxiey X child rs4680) increased
the percentage variance explained in our model of child backwards digit span by 0.2%. These
results were largely unchanged following adjustment for multiple testing (see S1 File). This
effect was specific to backward digit span and did not extend to forward digit span or total IQ
(data not shown; available from the authors); furthermore, the strength of this interaction was
unchanged when child total IQ was covaried in the regression model (see S1 File).
Child COMT rs4680 genotype, maternal prenatal anxiety and ADHD
symptoms from age 4 to 15 years
Prenatal maternal anxiety at 32 weeks gestation predicted child ADHD symptoms at 4 years of
age (B = 0.087, SE = 0.021, β = 0.127, p<0.001), independent of a number of covariates, includ-
ing child rs4680 (see Table 2 and S1 File). This regression model accounted for approximately
9% of the variance in child outcome (R2 = 0.094, p<0.001). Prenatal maternal anxiety at 32
weeks gestation remained a significant predictor of the likelihood of ADHD at 15 years of age
(B = 0.039, SE = 0.009, β = 0.190, p<0.001) in a regression model that accounted for approxi-
mately 5% of the variance in outcome (R2 = 0.046, p<0.001). The persistence of maternal pre-
natal anxiety predicting ADHD symptoms from 4 to 15 years was found despite modest
stability in ADHD symptoms between these assessments (r = 0.246, p<0.001). The prediction
from prenatal maternal anxiety was significantly moderated by child rs4680 genotype for
ADHD symptoms at 4 and 15 years. The addition of the interaction terms (maternal prenatal
anxiety X child rs4680) to our models increased the percentage variance explained in child and
adolescent outcomes by 0.1% and 0.5%, respectively. After correction for multiple testing car-
riers of the val/val genotype exposed to higher levels of maternal prenatal anxiety showed
higher symptoms of ADHD at age 4 year relative to val/met heterozygotes (adjusted p = 0.033)
but not met/met homozygotes (adjusted p = 0.120).
Prenatal anxiety, COMT and child outcome
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Likewise, carriers of the val/val genotype exposed to higher levels of maternal prenatal anxi-
ety showed a greater likelihood of ADHD at age 15 years relative to both met/met (p = 0.009)
and val/met genotypes (adjusted p = 0.006) (see Fig 2 and see S1 File).
Replication analyses
In the PREDO sample maternal prenatal anxiety predicted child symptoms of ADHD at
3.5years (B = 0.225, SE = 0.103, β = 0.227, p = 0.030) independent of a number of covariates,
including child rs4680. This regression model accounted for 17.1% of the variance in child out-
come (R2 = 0.171, p<0.001). Likewise, maternal prenatal anxiety interacted with child rs4680
Fig 1. Maternal prenatal anxiety, child rs4680 genotype and working memory at 8 years of age. Maternal ratings of prenatal anxiety at 32
weeks of pregnancy (x axis) were plotted against child working memory (backward digit span) assessed as part of the WISC = Wechsler
Intelligence Scale for Children at 8 years of age. Regression lines represent each of the three rs4680 genotypes: val/val (GG:blue), val/met (AG:
green) and met/met(AA: purple). yrs = years.
https://doi.org/10.1371/journal.pone.0177506.g001
Prenatal anxiety, COMT and child outcome
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Table 2. Maternal prenatal anxiety interacts with child rs4680 to predict symptoms of ADHD and working memory.
SDQ
(ADHD) 4yrs
DAWBA
(ADHD) 15yrs
WISC
(Backward Digit Span) 8yrs
§Model 1 β β β
Prenatal anxiety (32 wks) 0.06** 0.07** 0.01
Postnatal anxiety (8 wks) 0.05** 0.02 -0.03
Maternal anxiety (33 mths) 0.07*** - -
Maternal anxiety (8 yrs) - 0.10*** 0.01
COMT rs4680
val/val (reference) - - -
val/met -0.02 -0.03 >-0.01
met/met -0.01 -0.08** <0.01
§Model 2 (Interaction analysis)
Prenatal anxiety *val/val - - -
Prenatal anxiety *val/met -0.09* -0.15** 0.10**
Prenatal anxiety *met/met -0.07* -0.14** 0.10**
Each column represents results from independent regression models. Standardized regression coefficients (β) are presented for main effects models
(model 1) and regression models containing both main effects and an interaction term between maternal prenatal anxiety at 32 weeks gestation and child
rs4680 genotype (model 2).
§Both models include as covariates parenting behavior, maternal age at time of pregnancy, smoking and substance abuse during pregnancy,
socioeconomic indicators: maternal education and household crowding, obstetric outcomes: birth weight, gestational age and child gender; see S1 File for
full model output. ADHD = attention deficit and hyperactivity disorder; DAWBA = Development and Well-being Assessment, WISC = Wechsler Intelligence
Scale for Children.
*0.05, **0.01, ***0.001 unadjusted p-values. wks = weeks, mths = months, yrs = years.
https://doi.org/10.1371/journal.pone.0177506.t002
Fig 2. Maternal prenatal anxiety, child rs4680 genotype and symptoms of ADHD at 4 and 15 years of age. Maternal ratings of prenatal anxiety at
32 weeks of pregnancy (x axes) were plotted against child symptoms of ADHD from the Strengths and Difficulties Questionnaire (SDQ) at age 4 (left
panel) and the likelihood of ADHD computed from the Development and Well-Being Aseessment (DAWBA) at age 15 years (right panel). Regression
lines represent each of the three rs4680 genotypes: val/val (GG:blue), val/met (AG: green) and met/met(AA: purple). ADHD = attention deficit and
hyperactivity disorder. yrs = years.
https://doi.org/10.1371/journal.pone.0177506.g002
Prenatal anxiety, COMT and child outcome
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genotype to predict elevated symptoms of ADHD at 3.5years (B = -0.234, SE = 0.113, β =
0.170, p = 0.040), increasing the percentage variance explained in child outcome by 0.9% (R2 =
0.180, p<0.001). Analyses stratified by genotype demonstrated that the effects of maternal pre-
natal anxiety on child symptoms of ADHD were most pronounced in carriers of the val/val
genotype (B = 0.226, SE = 0.142, β = 0.242, p = 0.065) relative to both val/met (B = 0.070,
SE = 0.079, β = 0.076, p = 0.378) and met/met groups (B = 0.156, SE = 0.109, β = 0.152,
p = 0.153).
Supplementary analyses
Several sets of analyses were conducted to examine the robustness and specificity of the prena-
tal anxiety X child COMT genotype interaction in the prediction of markers of neurodevelop-
ment. First, we tested if our results were inflated by heteroskedascity within our data (see [19]).
We found significant variance inflation in child ADHD symptoms scores at age 4 and 15 years
as a function of maternal prenatal anxiety (see S1, S2 and S3 Figs). The interaction between
maternal prenatal anxiety and child rs4680 predicted child working memory (robust joint test
corrected p = 0.019) and ADHD symptoms at age 15 years (robust joint test corrected p<0.01)
using models robust to heteroscedasticity, but the robust joint test indicated that the interac-
tion between maternal prenatal anxiety and child rs4680 was reduced (corrected p = 0.16). The
reliability of the prenatal maternal anxiety X child COMT genotype was also suggested when
we applied an analytic approach suggested by Keller [38]. This approach requires the inclusion
of all two-way interactions between the genetic predictor (G: rs4680), the environmental factor
(E: maternal prenatal anxiety) and all other covariates (C) within a linear model. The inclusion
of all G x C and E x C terms did not substantively change our results for comparisons between
val/val and met/met homozygotes. For example, carriers of the val/val genotype exposed to
higher levels of maternal prenatal anxiety had shorter backward digit span (p = 0.019) and sig-
nificantly more symptoms of ADHD at 4 (p = 0.048) and 15 years of age (p = 0.024) relative to
the met/met group.
Next, we examined if maternal prenatal anxiety interacted with maternal rs4680 genotype
to predict child outcome. It did not. The interaction term between maternal prenatal anxiety
and maternal rs4680 did not predict child working memory (interaction terms all p>0.495) or
child ADHD symptoms at 4 (interaction terms all p>0.333) or 15 years (interaction terms all
p>0.565), and including the interaction by maternal COMT genotype did not substantively
alter the interaction effect for child COMT genotype. Next, on the subset on whom paternal
data in pregnancy were available, there was not reliable evidence for a genetic moderation of
the prenatal paternal anxiety effect for working memory or inattention and hyperactivity at
ages 4 and 15 years of age (details available from the authors).
Likewise, maternal prenatal anxiety at 32 weeks was the only measure of maternal mood in
the pre or postnatal period to significantly interact with child COMT genotype to predict all of
the three neurodevelopmental outcomes examined in this study, i.e., there was not a postnatal
maternal anxiety X child COMT genotype interaction (see S1 File). We then examined if the
genetic moderation of the prenatal maternal anxiety effect extended to prenatal maternal
depression at 18 or 32 weeks. The effects were similar, but somewhat weaker (see S2 File).
Finally, we considered BDNF polymorphisms as an alternative genetic moderator, given its
known role in neurodevelopment and a prior finding from this sample suggesting that BDNF
moderated the association between prenatal anxiety and internalizing symptoms [36]. There
was no evidence that BDNF SNPs (rs11030121 and rs7124442) moderated the association
between maternal prenatal anxiety and child neurodevelopmental outcomes (details available
from first author).
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Discussion
By capitalizing on 15 years of data from a large community sample and an independent repli-
cation sample, we extended the research base on the prenatal developmental programming
hypothesis by demonstrating a genetic moderation of the prenatal prediction of key markers
of neurodevelopment in children and adolescence, and identifying catecholamine neurotrans-
mission as one mechanism by which prenatal maternal anxiety may alter child neurodevelop-
ment. The magnitude of the moderation effects was small, consistent with documented
genotype X environment interactions so far reported for neurodevelopmental outcomes;
nonetheless, the strengths of the study and the robustness of the prediction substantiate the
persisting effect implied by the programming hypothesis for child and adolescent
neurodevelopment.
To date, the mechanistic focus in research on prenatal maternal anxiety, depression and
stress and its effect on child development is the HPA axis; that derives from substantial evi-
dence from the experimental animal work [42]. Although there is now substantial evidence for
a prenatal maternal anxiety effect on several aspects of child behavioral and biological develop-
ment, confirmatory evidence for an HPA axis-linked mechanism is limited. That may reflect
significant limitations in identifying causal mechanisms in non-experimental human work;
alternatively, it may be that the mechanistic focus has been too narrow. Our finding that the
prenatal maternal anxiety effect is moderated by child rs4680 that regulates COMT, which is
involved in the inactivation of catecholamine neurotransmitters (dopamine, epinephrine, nor-
epinephrine), implies that a broader biological model for understanding prenatal maternal
anxiety effects is needed. Dopamine neurotransmission in the prefrontal cortex plays a major
role in mediating neurodevelopment, including executive function [43] and symptoms of inat-
tention and hyperactivity—although the latter remains a matter of some controversy [44]. Our
findings implicating COMT for regulating the prenatal maternal anxiety prediction of execu-
tive function and inattention/hyperactivity are of interest for identifying a potential mecha-
nism for work on prenatal anxiety and for expanding COMT-focused research on developing
neurocognitive functions. It is particularly notable that our analyses of more than ten years’ of
data from this large community sample is consistent with prior work on COMT moderating a
prenatal anxiety exposure based on smaller and/or younger samples [16, 17]. Findings in
ALSPAC and PREDO differ, at least in part, from those of Thompson et al., [17] who report
stronger effects of maternal perinatal perceived stress on a broad-band measure of child behav-
ioral and emotional problems in children homozygous for the met allele. It is not clear how to
interpret the differences in findings, however, given that >40% of the children in the Thomp-
son et al. study were born small for gestational age and their outcome measure incorporated a
wide array of behaviors.
A developmental programming pattern is suggested by the finding on a persisting associa-
tion between prenatal maternal anxiety and child outcomes through mid-adolescence [4, 45].
It remains to be seen if this effect extends into adulthood, which would further substantiate a
“programming” effect (although see [9, 10]). It is also notable that the prenatal maternal anxi-
ety prediction and genetic moderation were specific to working memory, rather than general
IQ, and that this prediction was unchanged after accounting for general cognitive ability. That
is notable given the particular interest in working memory and executive functions more
generally in relation to COMT and several neuropsychiatric disorders, such as ADHD, for
example.
How maternal anxiety in pregnancy may alter dopamine-linked brain development in the
child is unclear; several different kinds of effects are possible. Genes associated with regula-
tion of monoamines, such as COMT, are associated with the cortisol stress response [46], not
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ruling out an HPA axis-mediated effect. COMT expression in the fetal dorsolateral prefrontal
cortex (DLPFC) increases across pregnancy (S4 Fig)(see [47]), with recent work showing
prenatal enrichment of specific COMT transcripts within the developing brain (see [48]).
The transcriptional profile of COMT within the DLPFC contrasts with that of BDNF, which
is expressed at low levels in the fetal DLPFC. Future work is required to determine if these
developmental differences in gene expression may underlie our significant COMT G x E
findings and the absence of a BDNF G x E effect on child working memory and symptoms of
ADHD. Prenatal epigenetic regulation of COMT expression is also possible. Ursini et al.
report genotype-dependent associations between lifetime stress, DNA methylation of COMT
and working memory [49]. Moreover, the authors describe a positive correlation between
DNA methylation at the rs4680 locus and working memory and find lower DNA methyla-
tion in individuals homozygous for the rs4680 val allele exposed greater lifetime stress. Fur-
ther work is required to determine if maternal prenatal anxiety influences the epigenetic
regulation of COMT expression.
Several limitations of the study deserve mention. Although our prenatal maternal anxiety
and child COMT genotype interaction results are compatible with prior studies (assessing
children of different ages and using alternative phenotypes in some cases), an independent
sample with all outcome measures assessed (e.g., symptoms of ADHD from 4–15 years and
working memory) was not available for replication analyses. However, we do show that our
findings can be replicated, at least in part, in an independent sample using similar constructs
but different measures. Second, we relied on maternal reports for measures of prenatal anxi-
ety and child symptoms of ADHD at 3.5 (PREDO), 4 and 15 years (ALSPAC), introducing a
potential reporter bias. However, the interaction effect was also found for in-person testing
of backward digit span in the ALSPAC cohort, which would not be subject to reporter bias.
This study would also have been benefited from multi-informant reports of child/adolescent
symptoms (e.g., paternal and teacher), which increase the sensitivity of symptom checklists
for detecting psychiatric diagnoses [50]. Third, targeted candidate gene approaches have
their limitations, although we have demonstrated that our findings on ADHD symptoms at
age 15 and working memory are robust and not confounded by heteroskedasticity which can
inflate gene-environment associations [19]. Finally, as with virtually all other demonstrations
of GxE effects, the clinical implications of our findings may be limited given the small genetic
moderation effect, which accounted for less than 1% of the variance in all outcomes assessed.
Studies that use a genome-wide approach will be required to resolve the full extent, and clini-
cal relevance, of genetic moderation in the context of maternal prenatal mood and child out-
come. However, such studies will be methodologically challenging and complicated by the
potential specificity of GxE effects, as observed in the current study (and see [36]). In this
context, it should be noted the gene-environment effect size we report is somewhat compara-
ble to main-effect estimates derived from recent large-scale polygenic analyses of ADHD
[51].
The limitations of our study are offset by several strengths, including the longitudinal pro-
spective design from pregnancy through the child’s adolescence, comparatively large sample
size, extensive assessments that included in-person testing, detailed data that allowed us to
examine the developmental specificity of this gene-environment effect and evidence of replica-
tion in an independent sample.
Further research that capitalizes on the experimental leverage of prenatal intervention is
needed to extend these findings; further work is also needed on developmental changes in
COMT effects, as a primary predictor and as a moderator of the prenatal anxiety effect, given
age-based changes in COMT-related imaging effects that have been reported [52].
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